Sabtu, 13 April 2013

Design and Analysis of Bridging Studies

Design and Analysis of Bridging Studies
Author:
Edition: 1
Binding: Hardcover
ISBN: 1439846340

As the development of medicines has become more globalized, the geographic variations in the efficacy and safety of pharmaceutical products need to be addressed. Download Design and Analysis of Bridging Studies (Chapman & Hall/CRC Biostatistics Series) from rapidshare, mediafire, 4shared. To accelerate the product development process and shorten approval time, researchers are beginning to design multiregional trials that incorporate subjects from many countries around the world under the same protocol. Design and Analysis of Bridging Studies addresses the issues arising from bridging studies and multiregional clinical trials. For bridging studies, the book explores ethnic sensitivity, the necessity of bridging studies, types of bridging studies, and the assessment of similarity between regions based on bridging evidence. For multiregional clinical trials, t Search and find a lot of medical books in many category availabe for free download. Design and Analysis of Bridging Studies medical books pdf for free. For multiregional clinical trials, t



download

Related books


Confidence Intervals for Proportions and Related Measures of Effect Size (Chapman & Hall/CRC Biostatistics Series)


Confidence Intervals for Proportions and Related Measures of Effect Size illustrates the use of effect size measures and corresponding confidence intervals as more informative alternatives to the most basic and widely used significan

The BUGS Book: A Practical Introduction to Bayesian Analysis (Chapman & Hall/CRC Texts in Statistical Science)


Bayesian statistical methods have become widely used for data analysis and modelling in recent years, and the BUGS software has become the most popular software for Bayesian analysis worldwide. Authored by the team that originally developed this soft

Handbook of Statistics in Clinical Oncology, Third Edition


Many new challenges have arisen in the area of oncology clinical trials. New cancer therapies are often based on cytostatic or targeted agents, which pose new challenges in the design and analysis of all phases of trials. The literature on adaptive t

Tidak ada komentar:

Posting Komentar